Executive Summary
The PTAB denied MIM Software's request to review claims in Progenics' medical image analysis patent. The denial was based on Petitioner's failure to provide a clear, single claim construction for key terms like 'risk map.'
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in MIM Software Inc. et al. vs Progenics Pharmaceuticals, Inc. et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Samsung Austin Semiconductor, LLC et al.vsSung, Chien-Min
Samsung Austin Semiconductor challenges the '802 Patent covering Chemical Mechanical Planarization (CMP) pad dressing technology. The Petitioner argues that prior art references, including Tsai et al., anticipate or render obvious all 21 claimed claims. This is a foundational challenge to the patent's validity in semiconductor manufacturing.
Shenzhen Tuozhu Technology Co., Ltd. et al.vsStratasys, Inc. et al.
The PTAB institution decision found Petitioner's arguments of obviousness under 35 U.S.C. § 103 sufficiently meritorious to proceed. The Board specifically noted that Claim 1 was likely unpatentable over Mazumder and Mori, adopting the petitioner’s definition of ordinary skill in the art.
Guardant Health, Inc.vsCold Spring Harbor Laboratory
The USPTO Board denied the institution of an Inter Partes Review (IPR) petition. The denial was based on a review of the merits, finding that the petitioner could not demonstrate a reasonable likelihood of prevailing.
Samsung Electronics Co., Ltd. et al.vsCerence Operating Company et al.
The PTAB institution decision found a reasonable likelihood of prevailing for Samsung against Cerence regarding claims related to voice messaging in mobile devices. The Board accepted the Petitioner's mapping that prior art discloses key elements, despite challenges from the Patent Owner on claim definitions.
Google LLCvs138 East LCD Advancements Limited et al.
The PTAB found all ten challenged claims unpatentable over prior art (Kuwata, Fisher, and Ohga). The Board concluded that combining Kuwata's image processing capabilities with network functionality from Fisher and color profile data from Ohga was obvious. This decision provides strong support for the Petitioner's position regarding the combination of existing technologies in digital imaging control.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.